Skip to main content

Infectious Dermatology

Infectious Dermatology

Featured

Derm Q&A
While the upper respiratory tract symptoms of the novel SARS-CoV-2 virus are widely recognized, new reports are suggesting possible skin manifestations among patients with the COVID-19. In an interview with The Dermatologist, Esther Freeman, MD, PhD, principle investigator, discussed the COVID-19 Dermatology registry in collaboration with the American Academy of Dermatology (AAD) and what the AAD hope to learn from providers across disciplines who are submitting cases.
News
Findings from two European studies published in JAMA Dermatology assessed the potential association between chilblains and COVID-2019.
Derm Q&A
While the upper respiratory tract symptoms of the novel SARS-CoV-2 virus are widely recognized, new reports are suggesting possible skin manifestations among patients with the COVID-19. In an intervie
Cover Story
Coronavirus disease, or COVID-19, may still be novel to the dermatology community, but research since its initial appearance in humans have elucidated some of the mystery around the virology and epidemiology of SARS-CoV-2.
Derm Q&A
Jules Lipoff, MD, spoke with The Dermatologist about treating patients with blistering autoimmune disease during the COVID-19 pandemic, including treatment considerations and common questions patients
Back to Top